Cargando…

肺癌患者化疗期间联合营养支持治疗的研究进展

Primary lung cancer is one of the most common malignancies. Nowadays, both its morbidity and mortality rank first, patients with lung cancer are often goes with some affiliating symptoms such as malnutrition and weight loss. The side effects of cytotoxicity during chemotherapy may lead to further de...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000412/
https://www.ncbi.nlm.nih.gov/pubmed/25539613
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.12.08
_version_ 1783331716132241408
collection PubMed
description Primary lung cancer is one of the most common malignancies. Nowadays, both its morbidity and mortality rank first, patients with lung cancer are often goes with some affiliating symptoms such as malnutrition and weight loss. The side effects of cytotoxicity during chemotherapy may lead to further deteriorate of the nutritional status and worsen the anti-tumor therapy's efficacy and the patients' quality of life. With the development of palliative treatment and the higher request of patients for quality of life, nutritional support will be an important adjunctive treatment to maintain a good nutritional status and enhance the patients' immunity during chemotherapy. It will play an active role in improving tolerability of chemotherapy and prognosis for patients with lung cancer. Here is a review about research progress of nutrition support treatment during chemotherapy for the patients with lung cancer.
format Online
Article
Text
id pubmed-6000412
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60004122018-07-06 肺癌患者化疗期间联合营养支持治疗的研究进展 Zhongguo Fei Ai Za Zhi 综述 Primary lung cancer is one of the most common malignancies. Nowadays, both its morbidity and mortality rank first, patients with lung cancer are often goes with some affiliating symptoms such as malnutrition and weight loss. The side effects of cytotoxicity during chemotherapy may lead to further deteriorate of the nutritional status and worsen the anti-tumor therapy's efficacy and the patients' quality of life. With the development of palliative treatment and the higher request of patients for quality of life, nutritional support will be an important adjunctive treatment to maintain a good nutritional status and enhance the patients' immunity during chemotherapy. It will play an active role in improving tolerability of chemotherapy and prognosis for patients with lung cancer. Here is a review about research progress of nutrition support treatment during chemotherapy for the patients with lung cancer. 中国肺癌杂志编辑部 2014-12-20 /pmc/articles/PMC6000412/ /pubmed/25539613 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.12.08 Text en 版权所有©《中国肺癌杂志》编辑部2014 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
肺癌患者化疗期间联合营养支持治疗的研究进展
title 肺癌患者化疗期间联合营养支持治疗的研究进展
title_full 肺癌患者化疗期间联合营养支持治疗的研究进展
title_fullStr 肺癌患者化疗期间联合营养支持治疗的研究进展
title_full_unstemmed 肺癌患者化疗期间联合营养支持治疗的研究进展
title_short 肺癌患者化疗期间联合营养支持治疗的研究进展
title_sort 肺癌患者化疗期间联合营养支持治疗的研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000412/
https://www.ncbi.nlm.nih.gov/pubmed/25539613
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.12.08
work_keys_str_mv AT fèiáihuànzhěhuàliáoqījiānliánhéyíngyǎngzhīchízhìliáodeyánjiūjìnzhǎn
AT fèiáihuànzhěhuàliáoqījiānliánhéyíngyǎngzhīchízhìliáodeyánjiūjìnzhǎn